Product Name:Methanesulfonamide

IUPAC Name:methanesulfonamide

CAS:3144-09-0
Molecular Formula:CH5NO2S
Purity:95%+
Catalog Number:CM342047
Molecular Weight:95.12

Packing Unit Available Stock Price($) Quantity
CM342047-1000g in stock řƩ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:3144-09-0
Molecular Formula:CH5NO2S
Melting Point:-
Smiles Code:CS(=O)(N)=O
Density:
Catalog Number:CM342047
Molecular Weight:95.12
Boiling Point:
MDL No:MFCD00007940
Storage:

Column Infos

Masofaniten
ESSA Pharma presents the updated phase 1 Masofaniten clinical data at the 2024 ASCO Genitourinary Cancers Symposium. Masofaniten (EPI-7386) is a first-in-class investigational, N-terminal domain (NTD) androgen receptor (AR) inhibitor under development for prostate cancer. The androgen receptor (AR) signaling pathway is responsible for growth and survival of most prostate cancers. Unlike present therapies by binding to the ligand-binding domain (LBD) of AR and inducing drug resistance, Masofaniten offers a unique mechanism that inhibits AR activity through targeting the N-terminal domain (NTD) of the AR and suppresses AR transcriptional activation.
Masofaniten is studied with Enzalutamide in the phase 1/2 clinical trial for metastatic castration-resistant prostate cancer (mCRPC) patients on androgen deprivation therapy and naïve to second-generation antiandrogens.